Caspase-8’s non-apoptotic role is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection.
Ontology highlight
ABSTRACT: Excessive inflammation and cytokine release are hallmarks of severe COVID-19. Programmed cell death is known to drive inflammation, however, its relevance in the pathogenesis of severe COVID-19 is unclear. Using a combination of gene-targeted murine models and transcriptomic approaches we found that excessive cytokine release and inflammation are dependent on caspase-8. Loss of caspase-8 significantly reduced disease severity and viral loads in vivo. Importantly, this phenotype was not attributable to caspase-8’s role in apoptosis but was instead linked to a decrease in IL-1β levels and inflammation. Combined deficiency of pyroptosis, necroptosis, and apoptosis mediators (Caspase1/11/12/8/Ripk3-/-) provided no added benefit in ameliorating disease outcomes compared to C8/R3-/- mice. Transcriptional profiling of lung tissues in mice lacking caspase-8, and in compound mutants lacking caspase-8 and other additional caspases and mediators, confirmed that disease outcomes were not associated with transcription differences in cell death pathways, but rather to differences in pro-inflammatory responses. The expression of caspase-8 and FLIP was increased in the lungs of SARS-CoV-2 infected mice. Collectively, these findings identify a pivotal role for caspase-8 in driving the pathogenesis of severe SARS-CoV-2 infection through the modulation of pro-inflammatory cytokines but not through the induction of apoptosis.
INSTRUMENT(S):
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Lung
DISEASE(S): Covid-19
SUBMITTER:
Maria Tanzer
LAB HEAD: Marcel Doerflinger
PROVIDER: PXD057656 | Pride | 2025-09-20
REPOSITORIES: Pride
ACCESS DATA